Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma

The excellent results for monoclonal antibodies in the treatment of severe uncontrolled asthma (SUCA) represent a milestone in current treatment of asthmatic disorders. Remaining, however, are several subsidiary areas for improvement in which new biologics are expected to make a decisive contributio...

Descripción completa

Detalles Bibliográficos
Autores principales: Plaza, Vicente, Cañete, Conxa, Domingo, Christian, Martínez Rivera, Carlos, Muñoz, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369521/
https://www.ncbi.nlm.nih.gov/pubmed/37496871
http://dx.doi.org/10.1016/j.opresp.2022.100231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369521/
https://www.ncbi.nlm.nih.gov/pubmed/37496871
http://dx.doi.org/10.1016/j.opresp.2022.100231

Ejemplares similares